Podcasts about Novo

Veja também em youtube.com/@45_graus Pedro Conceição é diretor do Gabinete do Relatório de Desenvolvimento Humano na ONU, a publicação anual onde é publicado o Índice de Desenvolvimento Humano, juntamente com outros indicadores de desenvolvimento. O convidado é licenciado em Física pelo Instituto Superior Técnico e em Economia pelo Iseg e doutorado em Políticas Públicas pela Lyndon B. Johnson School of Public Affairs da Universidade do Texas em Austin, onde estudou com uma Bolsa Fulbright. _______________ Índice: De que falamos quando falamos de desenvolvimento humano? | Índice de Desenvolvimento Humano da ONU (IDH) Que países surpreendem no ranking de IDH face ao PIB? Governos levam o ranking muito a sério; às vezes demasiado. Que outros indicadores de desenvolvimento poderíamos acrescentar ao o índice? Desigualdade | Ambiente | Democracia e direitos humanos | Indicadores de saúde e educação mais precisos Paper Luís Bettencourt: Community Human Development Index Paper que usa IA e imagens de satélite para estimar IDH. Novo indicador do Banco Mundial, com métrica única de qualidade da educação Quais foram os países com melhor e pior evolução nas últimas décadas? Porque abrandou o crescimento do IDH no Mundo nos últimos anos? Os países começaram a divergir É possível aos governos “game” os indicadores de IDH, ou seja, passarem a gerir para o IDH sem gerar as melhorias de desenvolvimento subjacente?See omnystudio.com/listener for privacy information.

Este boletim traz um resumo das principais notícias do dia na análise de Samuel Possebon, editor chefe da TELETIME.TELETIME é a publicação de referência para quem acompanha o mercado de telecomunicações, tecnologia e Internet no Brasil. Uma publicação independente dedicada ao debate aprofundado e criterioso das questões econômicas, regulatórias, tecnológicas, operacionais e estratégicas das empresas do setor. Se você ainda não acompanha a newsletter TELETIME, inscreva-se aqui (shorturl.at/juzF1) e fique ligado no dia a dia do mercado de telecom. É simples e é gratuito.Você ainda pode acompanhar TELETIME nas redes sociais:Linkedin: https://www.linkedin.com/company/teletimenews/Facebook: https://www.facebook.com/Teletime/ Ou entre em nosso canal no Telegram: https://t.me/teletimenews Hosted on Acast. See acast.com/privacy for more information.

No podcast ‘Notícia No Seu Tempo’, confira em áudio as principais notícias da edição impressa do jornal ‘O Estado de S.Paulo’ desta quarta-feira (25/02/2026): O Supremo Tribunal Federal (STF) e o Congresso Nacional firmaram acordo para propor regra de transição para os penduricalhos, indenizações que resultam em remunerações para servidores públicos acima do teto constitucional de R$ 46.366,19. O acordo foi fechado pelos presidentes do STF, Edson Fachin, do Senado, Davi Alcolumbre, e da Câmara dos Deputados, Hugo Motta , em reunião com a presença dos ministros Gilmar Mendes e Flávio Dino. No começo do mês, em liminar, Dino ordenou os Três Poderes cortarem os pagamentos sem amparo legal. Anteontem, Mendes determinou a suspensão de penduricalhos no Judiciário e no Ministério Público com base em leis estaduais, decisões internas e atos administrativos. No caso da Justiça Federal e do Ministério Público da União, a ordem prevê interrupção de valores sem amparo da lei aprovada pelo Congresso. E mais: Política: PGR sustenta que Marielle foi morta porque ‘ameaçou currais eleitorais’ Economia: Operação irregular envolve venda de precatório de usina ao Master Internacional: Investigação aponta falta de arquivos de Epstein que ligam Trump a abuso Metrópole: Deslizamentos matam dezenas em Minas; previsão é de mau tempo See omnystudio.com/listener for privacy information.

Et kommende blockbuster-håb og et nyt skidt resultat. Mandag tog Novo et ordentligt dyk på børsen, og selvom tirsdag var bedre, var den stadig blodig. Årsagen skal findes i et nyt studie, der viser, at Novos kommende fedmehåb Cagrezema underpræsterede i forhold til konkurrenten Eli Lillys Zepbound. Spørgsmålet for Novo må snart være, hvornår den uendelige kaskade af dårlige nyheder synes at stoppe, og hvad Novo kan gøre for at vende den nærmest uendelige nedtur. Få svarene i denne Finans lyn-analyse. Gæst: Nick Sturm, journalist, Finans. Vært: Mads Ring. Foto: Thomas Lekfeldt:See omnystudio.com/listener for privacy information.

Todas as manhãs, acompanhe o Momento Mercado e comece o dia por dentro do cenário econômico. É um conteúdo rico, com linguagem leve, que traz o fechamento de mercado do dia anterior e os principais destaques do dia atual. Siga nosso canal e acompanhe nossos conteúdos diários! #MercadoFinanceiro #InvestirMelhor #PodcastSpotify #NovoPodcast #Dinheiro #Economia #MomentoInvestidor #Bradesco #MomentoMercado #MorningCall #Investimentos #RendaVariável #Ações #Ibovespa #Câmbio #DólarSee omnystudio.com/listener for privacy information.

The Big Ones

Send a textThis episode unpacks Novo's aggressive price cuts, Lilly's head to head trial win, and the emerging triple agonist race, revealing how pricing strategy and next generation data are colliding in a full scale GLP-1 market war.00:00 – Cold Open: Lilly vs Novo Shock TimingDave opens with the bombshell that Novo funded a tirzepatide trial while simultaneously announcing major price cuts to Wegovy and Ozempic, setting up a strategic chess match.03:20 – Novo Nordisk Price Cuts ExplainedDeep dive into Novo's plan to cut list prices by up to 50% and what that actually means for formulary power, PBMs, and competitive positioning.07:25 – Tirzepatide vs Semaglutide Head to Head TrialBreakdown of the direct comparison study showing stronger weight loss with tirzepatide and what that means clinically and commercially.11:55 – Market Reaction and Strategic ImplicationsDiscussion of stock movement, competitive signaling, and how Novo's pricing move may blunt Lilly's trial victory.14:25 – Novo Triple Agonist Data DropsShift into Novo's early phase data on its triple agonist candidate and how it compares conceptually to existing dual agonists.16:00 – Comparing Novo's Triple to RetatrutideAnalysis of weight loss percentages versus Lilly's retatrutide data and the caution required when comparing across trials.18:15 – The Triple Agonist EraBroader conversation about whether triple agonism consistently pushes weight loss higher and what durability may look like long term.20:00 – Clinical Trial Results vs Real World RealityReminder that clinical trial outcomes do not automatically translate to everyday patient experience.22:30 – Data Refresher on Allurion Ballon ApprovalQuick recap of the headline numbers and strategic landscape as innovation and pricing Visit TRYSHED.COM to learn more today! Use CODE OTP25 to save 25%!

Stemningen omkring de danske aktier synes at være på et nulpunkt, efter et nyt tørt kurshug til medicinalgiganten Novo Nordisk mandag. Efter en stærk start på året er C25-indekset nu nede med 4 pct. i 2026 og nedturen for Novo Nordisk er nu så voldsom, at aktien er nede med 75 pct. fra toppen. Spørgsmålet er, hvor det efterlader investorerne, og om der stadig kan være gode investeringsmuligheder i de danske aktier. Det diskuterer Millionærklubben med chef for danske aktier i Danske Bank Asset Management Esben Saxbeck Larsen og chefanalytiker i Svenssen & Tudborg Lau Svenssen. Vært: Adam GeilSee omnystudio.com/listener for privacy information.

Izteka se javna razprava za novi pravopis. Ta temeljni jezikoslovni priročnik nastaja v stalnem dialogu z javnostjo. Kaj lahko pričakujemo po večletni javni razpravi v Pravopisu 8.0, osmem po vrsti, kako velike bodo spremembe? Največje spremembe se nanašajo na napovedano odločitev pri veliki začetnici, pri izjemah zapisa z malo začetnico pri pisanju krajevnih imen (vas, mesto, trg, selo, selce …). Odločitev, ali bomo od letos, ko naj bi bil dokončan Pravopis 8.0, zapisovali npr. Novo Mesto in ne več Novo mesto, sicer še ni dokončno sprejeta. Gostja oddaje je dr. Helena Dobrovoljc, vodja skupine za pripravo novega pravopisa.

Gaivota atingida por bola durante um jogo, conseguiu recuperar graças às manobras de reanimação de um jogador! Como estragar uma vitória numa corrida de mais de três horas e meia?!

Fast Money is live from sunny Miami Beach for the iConnections Global Alts Conference, as stocks try to find their footing with tariffs, AI, and financials all in the crosshairs. Plus, we dig into the state of private credit as fresh concerns ripple through the space. And don't miss the next move in crypto after a drop below $65,000, Novo's selloff on new trial results, and the opportunities in Japan as the Nikkei hovers just below records.  Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

SEND US A TEXT MESSAGE!!! Let Drs. Nii & Renee know what you think about the show!Two first-gen doctors answer your real questions: How to open a business bank account, and whether starting Medical school at 40 is still possible. This week's Q&A covers two questions that represent completely different stages of the first-gen doctor journey: a neurology resident finishing training and building her business, and a 40-year-old premed, wondering if the dream of becoming a doctor is still possible.THIS WEEK'S QUESTIONS:QUESTION 1 — From Mouna (Neurology Resident):"I just created my LLC to do locum work, and I'm looking into opening a business bank account. Do you recommend a traditional bank versus newer online banks? Some of the online options have built-in bookkeeping tools — do you have experience or a preference?"QUESTION 2 — From YouTube Comments:"I am 40, coming from a career as a psychotherapist, married with children, with a mortgage, and $135K in student loan debt. I'm considering general surgery, psychiatry, neurology, internal medicine, and family medicine. I'm taking one class at a time and targeting 2030 for application. Any advice?"SUBMIT YOUR QUESTION FOR NEXT WEEK:We do Q&A episodes every week and we read every question submitted. Here is how to reach us:

Carl Quintanilla, Sara Eisen, and David Faber kicked off a snowy morning with a look at the broader markets, and where tariff rates stand - as stocks take a leg lower following last week's SCOTUS decision. Charles Schwab's Chief Strategist Liz Ann Sonders joined the team with more on what it all means for stocks - before longtime geopolitical expert Ian Bremmer from Eurasia group gave his take on the impact for already-made trade deals. Plus: the 130 billion dollar question... Who will get a tariff refund? Hear a read from the ground with the CEO of Flexport - whose new 'refund calculator' is already getting use from Fortune 500 companies.  Around the edges: details on the trial results hitting Novo Nordisk shares, and the latest on media names as President Trump threatens Netflix over a board member's political comments.  Squawk on the Street Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Novo Nordisk Chief Scientific Officer Martin Holst Lange discusses the recent clinical trial results of the company's weight loss obesity shot CagriSema, which delivered less weight loss than Eli Lilly’s tirzepatide. Holst Lange also outlines Novo Nordisk's broader obesity treatment pipeline. He speaks with Bloomberg's Dani Burger. See omnystudio.com/listener for privacy information.

No episódio de hoje do Check-up Semanal, o Dr. Ronaldo Gismondi, editor-chefe médico do Portal Afya e do Whitebook, comenta os principais destaques recentes em Ginecologia e Obstetrícia, com foco em terapia hormonal na menopausa, decisões no segundo estágio do parto, analgesia para inserção de DIU, impacto dos miomas intramurais na FIV e abordagem diagnóstica do hCG positivo.Leia na íntegra os artigos mencionados hoje:Atualização Cochrane 2025 sobre terapia de reposição hormonal na pós-menopausaParto vaginal operatório X cesárea no período expulsivo: qual a opção mais seguraEficácia e segurança de anestésicos tópicos na inserção de DIUMiomectomia em miomas intramurais antes da FIV: o que dizem as evidências atuais?Novo Consenso Clínico do ACOG sobre avaliação do hCG

Fernando Silva (Chega) e Pedro Vaz (PS) apresentam algumas reservas relativas ao novo MAI, mas por motivos diferentes. Já António Rodrigues (PSD) garante que o programa do governo mantém-se o mesmo.See omnystudio.com/listener for privacy information.

Novo marco regulatório para registro de fitoterápicos da Anvisa estimula ampliação de oferta desses medicamentos com segurança e qualidade

Tarifaço de Trump: entenda as mudanças e como ficam as cobranças para o Brasil. Voos são cancelados por conta de tempestade de neve em Nova York. Hytalo Santos: influenciador e o marido são condenados por exploração sexual de adolescentes. Contrata+Brasil: veja como MEIs podem vender ao governo e quem pode participar. João Fonseca e Marcelo Melo arrancam virada e são campeões das duplas do Rio Open. Corinthians elimina a Portuguesa nos pênaltis e vai à semifinal do Paulistão e mais gols dos estaduais.

Novo ministro rejeita confusões com caso Spinumviva: “Diretor nacional não investiga ninguém”. E deixa avisos aos partidos: está aberto a propostas mas não as que “violem” a sua “consciência”.See omnystudio.com/listener for privacy information.

O Concello de Valdoviño celebrou hoxe o Día de Rosalía coa inauguración do novo mural do artista local Manuel Carballeira, dedicado a Rosalía de Castro. A obra, inspirada no histórico billete da Fábrica Nacional de Moneda y Timbre que nos anos 70 converteu á autora na primeira muller non real en protagonizalo, está situada na contorna da praia pequena da Frouxeira. O mural pasa a integrar o espazo rosaliano do municipio, xunto á Rosalía surfeira e outras interpretacións creadas por Carballeira. A peza inclúe textos e imaxes orixinais, como a estampa da praia no billete. O Concello anima á veciñanza a visitar a obra e sumarse á homenaxe.

Estratégia das Marcas | Marcelo Lyra, vice-presidente de RI, ESG e Comunicação da Acelen Renováveis, aborda o Acelen Valoriza e o potencial da macaúba para transformar regiões e fortalecer a agricultura familiar. Entrevista completa:#Patrocinado

Chaty, faça uma descrição para um episódio de podcast, sem parecer uma LLM (sem musica com direitos autorais)

» Culto de Celebração» Domingo Noite» Tema: Vestes Novas e Vinho Novo» Pregador: Pr. Sebastião Brito» Data: 22/02/2026#IBAlameda #Alameda #juventude---------------------------------------------------------------------------------------------------Nossos Cultos Online:► Libertação: SEXTA, às 20h► Juventude: SÁBADO, às 19h► Celebração: DOMINGO, às 10h e 18h30Acompanhe nossas Redes Sociais:► Facebook:   / igrejabatistaalameda  ► Instagram:   / igrejabatistaalameda  ► Youtube:    / igrejabatistaalameda  ► Site: https://igrejabatistaalameda.com.br/

Após forte repercussão, Filipe Luís voltou a falar sobre o caso de racismo envolvendo Vinícius Júnior. O técnico do Flamengo abriu a coletiva, reforçou apoio ao jogador e cobrou punições mais duras.No vídeo, analisamos as quatro manifestações do treinador, o impacto da expressão “caso isolado”, a conversa com Danilo e o peso da palavra de um técnico em um clube do tamanho do Flamengo.QUER FALAR E INTERAGIR CONOSCO?:        CONTATO I contato@serflamengo.com.br SITE I ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠serfla⁠me⁠ngo.com.br⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TWITTER I ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠BlogSerFlamengo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠INSTAGRAM I ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@BlogSe⁠rFlamengo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠#Flamengo #NotíciasDoFlamengo #ViniJr

O Acordo Paulista é o maior programa de recuperação fiscal do Governo de São Paulo e já viabilizou, nos últimos dois anos, a renegociação de R$ 58,4 bilhões em débitos inscritos na dívida ativa do Estado. Novo edital para renegociação de dívida recebe inscrições até 27 de fevereiro

Instituto Butantan completa 125 anos e recebe investimentos de R$ 1,38 bilhão para ampliação do parque fabril; celebração conta ainda com entrega antecipada de mais 1,3 milhão de doses da vacina contra a dengue

13h Luís Neves novo MAI

Confira nesta edição do JR 24 Horas: A guerra na Ucrânia chega ao quarto ano com um novo alerta sobre o número de vítimas civis. Desde o início da invasão russa, mais de cinco mil mulheres e meninas foram mortas no conflito. Imagens de uma guerra que já deixou quase dois milhões de mortos e feridos dos dois lados.  E ainda: Novo ataque dos EUA contra embarcação no Pacífico deixa três mortos.

Ventura vai comentar missas.

Debate da Super Manhã: Tema central da política em 2026, as eleições de outubro já estão marcadas com a corrida eleitoral e o papel dos partidos políticos na construção das chapas, das alianças, das estratégias e das expectativas rumo às urnas. No debate desta sexta-feira (20), a comunicadora Natalia Ribeiro conversa com os nossos convidados para falar sobre as candidaturas para o pleito deste ano, as articulações das siglas partidárias e o apoio dos prefeitos e lideranças. Participam o deputado federal Carlos Veras, presidente do PT em Pernambuco; o deputado estadual Sileno Guedes, presidente estadual do PSB; e o presidente do Novo em Pernambuco, Tecio Teles.

Confira nesta edição: Ministério da Educação divulga calendário de pagamentos do Pé-de-Meia, programa que beneficia estudantes matriculados no ensino médio. Novo relator do caso Master no STF, ministro André Mendonça amplia autonomia da Polícia Federal em investigações sobre possíveis fraudes no banco. Veja ainda: Lula inaugura escritório da Agência Brasileira de Promoção de Exportações na Índia.

Convidado: Fernando Abrucio, cientista político, professor da FGV-EAESP e comentarista da GloboNews. Então candidato de oposição ao governo de Jair Bolsonaro (PL), Lula (PT) surpreendeu o mundo político ao anunciar o convite para que Geraldo Alckmin (PSB) fosse o vice-presidente na chapa que concorreria nas eleições de 2022. O ex-tucano e adversário histórico do PT topou, e a estratégia deu certo: a dobradinha Lula-Alckmin se apresentou ao eleitor como representante de uma frente ampla e venceu a eleição. Quatro anos depois, presidente e vice demonstram ter excelente relação e trocam elogios em público, mas nada garante que a parceria irá se repetir na urna. Lula dá sinais de que a vaga está aberta para negociações com partidos de centro, como o MDB. O objetivo é ampliar alianças, conquistar mais palanques estaduais e municipais e aumentar o tempo de propaganda eleitoral. Na oposição, a pré-candidatura de Flávio Bolsonaro se consolida como a mais competitiva, de acordo com as pesquisas mais recentes. E já circulam especulações de potenciais candidatos a vice. Os mais citados são Romeu Zema, governador de Minas Gerais, do Novo, e Tereza Cristina, senadora pelo Mato Grosso do Sul, do PP. Para analisar a viabilidade de todas as estratégias eleitorais em jogo, Natuza Nery recebe o cientista político Fernando Abrucio. Ele, que é professor da FGV-EAESP e comentarista da GloboNews, comenta a situação de Geraldo Alckmin no governo e o que Lula busca nas conversas com partidos de centro; e avalia os nomes em torno de Flávio Bolsonaro.

Venha visitar a nossa Loja:https://iconografia-da-historia-3.myshopify.com/?utm_medium=product_shelf&utm_source=youtubeSiga nosso canal de CORTES:https://www.youtube.com/@IconografiadaHistoria-cortesE siga também nosso canal parceiro "CAFÉ E CAOS TV" apresentado pelo nosso querido Fernandão e Agnes Andradehttps://www.youtube.com/@CafeecaostvAJUDE-NOS A MANTER O CANAL ICONOGRAFIA DA HISTÓRIA: Considere apoiar nosso trabalho, participar de sorteios e garantir acesso ao nosso grupo de Whatsapp exclusivo: https://bit.ly/apoiaoidhSe preferir, faz um PIX: https://bit.ly/PIXidhNos acompanhe no Spotify @iconocastSiga ICONOGRAFIA DA HISTÓRIA em todas as redes: https://linktr.ee/iconografiadahistoriaoficialSiga o JOEL PAVIOTTI: https://bit.ly/joelpaviottiApresentação: Joel PaviottiTexto e roteirização: Adriana de PaulaRevisão: Adriana de PaulaCâmera e produção: Fernando ZenerattoEdição: Fernando ZenerattoDireção: Fernando Zeneratto / Joel Paviotti

Neste episódio falamos o novo plano do LinkedIn, a IA torna-te mais produtivo e muito mais

See omnystudio.com/listener for privacy information.

Novo estudo revela profundas desigualdades no acesso ao tratamento, sobretudo em países africanos e entre mulheres; cobertura da cirurgia deverá subir cerca de 8,4% nesta década; ritmo atual não chega para cumprir as metas globais até 2030.

O Bate-Pronto de hoje falará tudo sobre as principais informações do futebol mundial. O Palmeiras está confiante de que fechará a contratação do zagueiro Nino até o meio do ano? O áudio do VAR de Botafogo x Flamengo foi divulgado, e também tem a repercussão da forte entrada sofrida por Neymar no jogo contra o Velo Clube.

Neste episódio especial, Yuri Moraes e Roberto Sadovski revelam a Lista Definitiva dos Melhores Filmes de 2025. Analisamos os lançamentos mais aguardados e polêmicos do ano, desde o novo Superman de James Gunn até o documentário sem filtros de Kanye West (In Whose Name) e o retorno de Danny Boyle com a franquia Extermínio.Além das críticas de cinema, fazemos o anúncio oficial da nossa estreia no UOL com o programa Enquadrado. Contamos os bastidores da nova parceria, a saída de projetos anteriores e debatemos diretores divisivos como Lars Von Trier, Spielberg e Kleber Mendonça Filho com seu novo "O Agente Secreto".Se você busca indicações de filmes cult, blockbusters inteligentes e uma conversa honesta sobre a indústria cinematográfica, essa live é o guia essencial para o seu ano.

OIM afirma que milhares de pessoas que retornaram ao país ainda estão deslocadas e podem fugir novamente; temperaturas congelantes do inverno estão se tornando insuportáveis devido à escassez cada vez mais grave de eletricidade e aquecimento.

Nos encontre no Instagram: https://www.instagram.com/novachurchatlanta/

Confira os destaques de Os Pingos nos Is desta sexta-feira (13):O ministro do STF Dias Toffoli é alvo de dez pedidos de impeachment apresentados no Senado, sendo que três requerimentos citam o caso do Banco Master como principal motivação. A abertura do processo depende de decisão do presidente da Casa e, embora prevista na Constituição, nunca foi aplicada no Brasil. Novo relator do caso Banco Master no STF, o ministro André Mendonça se reuniu com delegados da Polícia Federal para entender o estágio das investigações e alinhar procedimentos. Após assumir a relatoria por sorteio, ele deve analisar pedidos de parlamentares e avaliar a possibilidade de levantamento do sigilo do processo, que foi imposto anteriormente na Corte. Uma sessão reservada do STF sobre a relatoria do caso Banco Master teve forte tom político e discussão interna entre os ministros. Após divergências, Dias Toffoli deixou a condução do processo, que foi redistribuído a André Mendonça. A divulgação de diálogos da reunião gerou suspeitas de gravação clandestina, hipótese negada posteriormente pelo ministro. Uma lancha naufragou durante o trajeto entre Manaus e Nova Olinda do Norte, nas proximidades do Encontro das Águas. Informações preliminares indicam que ao menos 70 pessoas foram resgatadas e que a embarcação não possuía coletes salva-vidas. O Corpo de Bombeiros do Amazonas foi acionado e a ocorrência segue em andamento, sem confirmação oficial do número de vítimas e feridos. A deputada federal Adriana Ventura (Novo-SP) reúne assinaturas para protocolar uma proposta de emenda à Constituição que torna obrigatória a adoção de um código de conduta e integridade no Judiciário brasileiro, incluindo ministros do STF e de tribunais superiores. Para começar a tramitar, a PEC precisa de 171 assinaturas, e, segundo a assessoria da parlamentar, 46 apoios já foram obtidos. O ministro do Empreendedorismo, Márcio França, afirmou estar apto a disputar o governo de São Paulo nas eleições de 2026, mas destacou que a decisão final caberá ao presidente Lula. Outros nomes, como Fernando Haddad, Simone Tebet e Geraldo Alckmin, também são cotados para compor uma eventual chapa do PT no estado.O presidente Lula se reuniu com o senador Rodrigo Pacheco e voltou a defender que ele dispute o governo de Minas Gerais para fortalecer o palanque do PT em 2026. Apesar da insistência, o parlamentar manteve a indefinição sobre a candidatura e afirmou que só concorreria se não houvesse alternativa competitiva no estado. A Câmara dos Deputados analisa um projeto de lei que prevê o pagamento de um 13º salário para famílias beneficiárias do Bolsa Família. A proposta busca garantir um fim de ano com maior suporte financeiro aos inscritos no programa social, mas ainda depende de tramitação e aprovação no Congresso Nacional. O Tribunal Superior Eleitoral indicou que o presidente Lula (PT) ainda pode sofrer sanções relacionadas ao desfile da escola Acadêmicos de Niterói, que prestará homenagem ao político. Apesar de não impedir a apresentação, a Corte fez ressalvas e manteve o processo em aberto, permitindo que partidos acionem novamente o TSE caso entendam que houve ato eleitoral antecipado. Você confere essas e outras notícias em Os Pingos nos Is.

O TSE rejeitou, por unanimidade, as ações do Novo e do Partido Missão contra o desfile da escola de samba Acadêmicos de Niterói, que vai homenagear Lula no Carnaval.Ao votar, a presidente do tribunal, Cármen Lúcia, disse que a rejeição não representa um “salvo-conduto” para ilícitos.Duda Teixeira e Madeleine Lacsko comentam:Papo Antagonista é o programa que explica e debate os principais acontecimentos do   dia com análises críticas e aprofundadas sobre a política brasileira e seus bastidores.     Apresentado por Madeleine Lacsko, o programa traz contexto e opinião sobre os temas mais quentes da atualidade.     Com foco em jornalismo, eleições e debate, é um espaço essencial para quem busca informação de qualidade.     Ao vivo de segunda a sexta-feira às 18h.    Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay   https://assine.oantagonista.com.br/  Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

O TSE rejeitou, por unanimidade, as ações do Novo e do Partido Missão contra o desfile da escola de samba Acadêmicos de Niterói, que vai homenagear Lula no Carnaval.Ao votar, a presidente do tribunal, Cármen Lúcia, disse que a rejeição não representa um “salvo-conduto” para ilícitos.Duda Teixeira e Madeleine Lacsko comentam:Papo Antagonista é o programa que explica e debate os principais acontecimentos do   dia com análises críticas e aprofundadas sobre a política brasileira e seus bastidores.     Apresentado por Madeleine Lacsko, o programa traz contexto e opinião sobre os temas mais quentes da atualidade.     Com foco em jornalismo, eleições e debate, é um espaço essencial para quem busca informação de qualidade.     Ao vivo de segunda a sexta-feira às 18h.    Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay   https://assine.oantagonista.com.br/  Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br 

Viajamos no tempo como um ninja, e depois um samurai, e depois um ninja em busca de vingança no receptivo Nioh 3. Comentamos também as demissões e futuro de 2XKO, Overwatch perdendo o número 2, o anúncio de Horizon Hunters Gathering, os resultados do PlayStation e da Obsidian e mais! Comece seu dia com a INSIDER #insiderstore Nosso cupom: JOGABILIDADE 00:08:59: Riot demite desenvolvedores de 2XKO 00:19:34: Blizzard remove o 2 de Overwatch 00:32:47: Novo CEO na Remedy Entertainment 00:34:37: Horizon Hunters Gathering foi anunciado 00:51:48: Resultados do trimestre do Playstation 01:06:26: O preço do Switch 2 01:12:26: Valve adia a Steam Machine 01:16:27: Resultados da Obsidian 01:23:08: Devs de Clair Obscur: Expedition 33 são condecorados 01:33:35: Série de Baldur's Gate 3 da HBO 01:40:38: Nioh 3 02:29:06: Perguntas dos ouvintes 02:42:33: Finalmentes Contribua | Twitter | YouTube | Twitch | Contato

Silver, Gold and Crypto (oh my) Hang on – Wild ride here Superbowl, Olympics- Wait until you hear about the CAPex spending! Shakeup in Dietville PLUS we are now on Spotify and Amazon Music/Podcasts! Click HERE for Show Notes and Links DHUnplugged is now streaming live - with listener chat. Click on link on the right sidebar. Love the Show? Then how about a Donation? Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter Interactive Brokers  Warm-Up - Silver, Gold and Crypto (oh my) - Need a stock for CTP - Hang on - Wild ride here - Superbowl, Olympics- Wait until you hear about the CAPex spending! - Shakeup in Dietville Markets - Massive moved during the week - - Bitcoin clipped $60k before rebounding - DJIA tops 50,000 for the first time - Wait until you hear about the CAPex spending! - CAT == 1,100 points on the DJIA in 2026 Superbowl and Superbowl ads - Game review - Any ad stick out? - $10M per ad this year - Half Time with Bad Bunny? - Anthropic busting on OpenAi Last Week! - Massive moved - quick calc showed that about $1T was wiped from market caps in the sell-off, particularly in tech names. - HOWEVER - Friday alone is estimated to have added $1.5T to market cap AI Ripping Through - Plenty of names getting cooked over AI announcements - First it was the software companies - Now there are names in legal and finance that got clocked - Today - Altruist.ai can do tax planning and that hurt companies in financial space Earnings Season Update - Reporting so far: 59% of S&P 500 companies have reported Q4 2025 results. - Beat rate: 76% have topped EPS estimates (vs. 5-yr average: 78% (slightly lower) vs. 10-yr average: 76% (in line) - Magnitude of beats (aggregate): earnings are 7.6% above estimates vs. 5-yr average: 7.7% (about the same) vs. 10-yr average: 7.0% (a bit better) - Nothing great,  like Goldilocks Earnings Highlights - Palantir (PLTR): Reported strong Q4 results early in the week , beating estimates with revenue ~$1.41B (vs. ~$1.33B expected) and EPS $0.25 (vs. $0.23). Guidance for 2026 was upbeat (~61% revenue growth). Shares rallied sharply initially (~7–11% post-earnings), but gave back some gains amid broader tech volatility (e.g., down ~11–22% in parts of the week from peaks). - AMD: Reported mid-week, beating EPS (~$1.53 vs. lower expectations) with solid data center growth (~39%). However, Q1 guidance disappointed relative to high expectations in the AI chip space. Shares sank dramatically — down ~15–17% the next day, with some reports noting up to 20%+ drops at points, contributing to broader chip sector pressure. - Alphabet (GOOGL/GOOG): Reported beating on revenue (~$113.8B) and EPS (~$2.82), with strong core performance. But capex guidance for 2026 ($175–$185B, roughly double prior levels) sparked AI spending worries. Shares dipped post-earnings (down ~0.5–5% initially, flat to lower the next day, with some volatility pulling it below key moving averages). - Amazon (AMZN): Reported after hours on February 5, with mixed results — EPS ~$1.95 (narrow miss vs. ~$1.97 expected), but solid overall. The big negative was a surprise $200B capex forecast for 2026 (well above expectations), tied to AI/cloud buildout. Shares plunged sharply — down ~7–10% in after-hours/extended trading, with Friday moves around -5–8% in some sessions. Recent Tech CAPEX announcements - Amazon (AMZN) — Guided to approximately $200 billion in capex for 2026 (a massive jump from ~$125–131 billion in 2025, with ~80% likely AI-related per analyst commentary). This was the largest single-company figure and a major surprise, contributing heavily to the week's "wild" reactions. - Alphabet (GOOGL/GOOG) — Guided to $175–185 billion in capex for 2026 (roughly double the $91 billion spent in 2025, far above analyst expectations of ~$115–119 billion). Emphasis was on AI compute capacity, servers, data centers, and networking to meet demand for Gemini and cloud services. - Meta Platforms (META) — Guidance from late January (but heavily discussed last week): $115–135 billion for 2026 (up significantly from ~$70–72 billion in 2025, potentially an ~87% increase). - Microsoft (MSFT) — No new full explicit 2026 guidance in early February (fiscal year runs July–June), but recent quarterly run-rate and analyst projections put it around $97–145 billion (with some sources citing ~$105 billion or higher based on Q2 spending trends and signals of continued growth from prior levels of ~$88 billion in FY2025). ------!!!!Combined 2026 capex projected at $635–665 billion (low/high ends) or up to $650–700 billion in some reports — a ~60–74% increase from their collective ~$381 billion in 2025. Market Reaction from all of this.... - Markets were a bit spooked on the Anthropic announcement earlier in the week - software sold off and set a sour mood - Microsoft dumped pretty hard as the amount of spend was higher than anticipated, especially with some slower growth in Azure. - Amazon took a beating on the increased spend they anticipate *(extra by $50B) - BUT: Friday markets rallied as there was realization that the $200B spend by Amazon would seep into the economy and fuel infrastructure spending along with chips, tech etc. Other Earnings of Interest -  Reddit reported fourth-quarter earnings on Thursday in which the social media company beat on the top and bottom lines. - The company said it expects first-quarter sales to come in the range of $595 million to $605 million, which is higher than Wall Street expectations of $577 million. - Reddit also announced a $1 billion share repurchase program. - Reddit gets about $250 million a year from OpenAi and Google to have your data for training their LLMs While we are on the subject - Friday, DJIA hit 50,000 - first time ever! - Up 1,200 point of which approx 350 was from caterpillar and 280 was from Goldman Sachs Hats off to WalMart - Walmart Inc. shares pushed its market capitalization past $1 trillion on Tuesday for the first time ever| - Big transformation over the pst year - Walmart has maintained its appeal to households looking for value, its online offerings are drawing new, wealthier shoppers seeking convenience. Google Bond Offering - Issuing several tranches of bonds, denominated in Stirling - one as long as 100 years - Would you buy that? - The Google parent is set to raise $20 billion from a US dollar bond offering on Monday — more than the $15 billion initially expected — and is also pitching investors on what would be its first ever offerings in Switzerland and the UK. - The latter would include a rare sale of 100-year bonds, the first time a tech company has tried such an offering since the dotcom frenzy of the late 1990s Fat Profits in Dietville - Really interesting sequence of events happening... - Hims launches compounded pill at prices as low as $49 per month - Analysts cite questions on efficacy, legality of pill - Hims' move shifts focus from Novo's strong Wegovy pill launch - Broader obesity market whipsawed as pricing pressure rises THEN.. - Hims and Hers Health shares dive 14% after hours on Friday (Down 25% on Monday) - FDA cites concerns over quality, safety, federal law - The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers, for its $49 weight-loss pill, including restricting access to the drug's ingredients and referring the company to the Department of Justice for potential violations of federal law. AND.... - Eli Lilly last Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. - The pharmaceutical giant anticipates its 2026 revenue will come in between $80 billion and $83 billion. Analysts expected revenue of $77.62 billion, according to LSEG. - Meanwhile, NOVO had a really bad outlook that took the shares down 13% after the report. Japan Markets Soar - Japanese stocks jumped to a record high Monday, leading gains in the region after Prime Minister Sanae Takaichi won a landmark election victory. - The ruling Liberal Democratic Party captured a two-thirds supermajority in the 465-seat lower house, public broadcaster NHK reported. - Japan's Nikkei 225 jumped past 57,000 for the first time before paring gains to close 3.9% higher at 56,363.94, while the Topix also notched a record high, closing at 3,783.94, up 2.3%. Employment Report? - Government shutdown is forcing them to postpone again (Which is dumb) - Number due this Wednesday - Maybe because of this:U.S. employers announced 108,435 layoffs for the month, up 118% from the same period a year ago and 205% from December 2025. The total marked the highest for any January since 2009. - At the same time, companies announced just 5,306 new hires, also the lowest January since 2009, which is when Challenger, Gray & Christmas began tracking such data. - Also, job openings fell sharply in December to 6.54 million, to their lowest since September 2020. - Available jobs are down by more than 900,000 just since October. - NO! Ai and advancements in tech have noting to do with this! NO NO NO M&A - Texas Instruments Inc. has reached an agreement to buy Silicon Laboratories Inc. for about $7.5 billion, deepening its exposure to several markets for chips. - Silicon Labs investors will receive $231 in cash for each share of the company's common stock and the transaction is expected to close in the first half of 2027. - The transaction still needs to win approval by investors in Silicon Labs and shares of Silicon Labs surged by 51% to $206.48 after the announcement. Inflation - This helps - PepsiCo (PEP.O), opens new tab will cut prices on core brands such as Lay's and Doritos by up to 15% following a consumer backlash against several previous price hikes, the snacks and beverage maker said on Tuesday after it topped fourth-quarter results. Miran - Moving - Federal Reserve Governor Stephen Miran is leaving his post as chair of the Council of Economic Advisers, CNBC has confirmed. - He joined the CEA in January 2025, but had been on leave from that post since last September when he filled the unexpired term of former Fed Governor Adriana Kugler.- He reamins on Fed board No Biggie???? - There are some astonishing cased being reported of Bad AI in the operating room - JNJ's TruDi Navigation System - Since AI was added to the device, the FDA has received unconfirmed reports of at least 100 malfunctions and adverse events. - At least 10 people were injured between late 2021 and November 2025, according to the reports. Most allegedly involved errors in which the TruDi Navigation System misinformed surgeons about the location of their instruments while they were using them inside patients' heads during operations. - Cerebrospinal fluid reportedly leaked from one patient's nose. In another reported case, a surgeon mistakenly punctured the base of a patient's skull. In two other cases, patients each allegedly suffered strokes after a major artery was accidentally injured. Cuba - The main airport has putt out a bulletin that they are out of Jet Fuel - Blackouts and lack of other fuels are creating big problems - No airlines have stopped running at this point, but many will as they cannot refuel - This is a bigger problem for cargo planes (supplies) that may not be able to risk flying to Cuba as they will not be able to get out. Love the Show? Then how about a Donation? ANNOUNCING THE WINNER OF THE THE CLOSEST TO THE PIN CUP 2025 Winners will be getting great stuff like the new "OFFICIAL" DHUnplugged Shirt!     FED AND CRYPTO LIMERICKS   See this week's stock picks HERE Follow John C. Dvorak on Twitter Follow Andrew Horowitz on Twitter

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: We are just over one week from our first Moms' Night Out event of the year. While the plans are all set – the speakers, the vendors, the raffles and the fun is ready to go, it's always amazing how many people hear of these event last minute. That's fine, they're welcome! But if you're thinking of attending a future event – registration is open for We're going to Nashville next March 6-7 and Detroit in September – no need to wait. And we've got Club 1921 events for health care professionals and patient leaders in 6 cities this year! All the info is over at diabetes-connetionss.com events/   Okay.. our top story this week: XX Gotta be a quick shout out to some incredible T1D athletes – we had TWO in the super bowl this past weekend – Chad Muma of the New England Patriots and Logan Brown of the Seattle Seahawks AND there are at least two athletes with type 1 competing at the Winter Olympics. Hannah Schmidt competes in ski cross for Canada – she was diagnosed with Type 1 diabetes at age 12 years old.  Anna FarnSchadt Fernstäd a Czech skeleton racer diagnosed in 2022 after she'd already been to several Olympics. We wish them all the best!   https://english.radio.cz/skeleton-racer-anna-fernstadtova-overcoming-adversity-headfirst-down-ice-8876699 XX The government website TrumpRx.gov is live..  the website does not sell prescription drugs. Instead, it allows people to look up their drugs and then navigate to buy them elsewhere, either from a major drug company or a pharmacy. The 43 drugs listed on the site have prices ranging from $3 to over $5,500. TrumpRx does include warnings that the site may not be the best option to save money on prescriptions. Each product page advises: "If you have insurance, check your co-pay first — it may be even lower." For now, the website says its prices are for people paying with their own money, rather than going through insurance. The only insulin listed right now is Lilly's insulin lispro – and it's the same price as you'd find through Illy's insulin value program. I looked up diabetes meds.. For example, if you have an insurance co-pay of $25 a month for Farxiga, a drug often used for diabetes, you would be paying $182 on TrumpRx. As you can imagine, though ,this is complicated and as with most of our healthcare system, it may be good in some cases and not much help in other.  I'd suggest calling your local pharmacist or checking with your human resource dept. https://www.nytimes.com/2026/02/06/health/trumprx-prescription-drug-prices-consumers.html XX Novo Nordisk will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the U.S. Food and Drug Administration has approved Ozempic tablets in three different doses. Novo says The new Ozempic name is intended to help patients and health care professionals more easily recognize the available treatment options for type 2 diabetes Semaglutide tablets have been available under the brand name Rybelsus Ruh BELL sis for diabetes since 2019 but with different dosing. The pill is also approved to reduce the risk of certain cardiovascular conditions in adults with type 2 diabetes who are at high risk for these events. The FDA had approved the new doses based on a bioequivalence study and the clinical trial data for Rybelsus, Novo said. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-launch-ozempic-pill-diabetes-second-quarter-this-year-2026-02-04/ XX https://www.contemporarypediatrics.com/view/early-screening-for-type-1-diabetes-found-effective-in-children XX Possible new way to identify and track the progress of type 1 diabetes before clinical onset. A recent study published in Science Advances described the application of subcutaneous microporous scaffolds. These are inserted and have been shown to  identify changes in cancer, multiple sclerosis, and T1D by capturing changes of immune cells over the course of a disease. This is a proof of concept study in mice.. so very early days. https://www.news-medical.net/news/20260204/Implantable-immune-scaffold-predicts-type-1-diabetes-weeks-before-symptoms.aspx XX A large global genetics study shows that many key drivers of Type 2 diabetes operate outside the bloodstream. In a major international project led in part by the University of Massachusetts Amherst and Helmholtz Munich in Germany, researchers linked hundreds of genes and proteins to the disease. The work, published in Nature Metabolism, points to a key challenge in diabetes research: the biology behind rising blood sugar does not play out the same way in every part of the body. It also shows why including people from many backgrounds matters, since genetic clues that stand out in one population may be faint or invisible in another. Huge study, 2.5 million people worldwide comparing patterns across seven tissues tied to diabetes and four global ancestry groups, then asked a simple question: what do you miss if you only measure blood? Across the seven tissues, the researchers found causal evidence pointing to 676 genes. Yet overlap with blood was limited: only 18% of genes with a causal effect in a primary diabetes tissue, such as the pancreas, showed a matching signal in blood. At the same time, 85% of genetic effects observed in diabetes-relevant tissues were completely absent from blood-based analyses. The findings lay out a roadmap for future research aimed at understanding the biological pathways underlying Type 2 diabetes and developing more effective treatments. https://scitechdaily.com/massive-global-study-rewrites-the-biology-of-type-2-diabetes/ XX Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies The settlement, first reported by Reuters, fits with that goal, and allows the FTC to pare down a case brought by the former Biden administration against Cigna's Express Scripts, UnitedHealth Group Inc's (UNH.N), Optum unit and CVS Health Corp's (CVS.N), CVS Caremark. The case against Optum and Caremark is ongoing. Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing practices. While the industry has already made reforms, the settlement gives the FTC power to enforce broader changes at Express Scripts. The 10-year agreement restricts Express Scripts' ability to engage in practices critics say contribute to high costs, like pocketing rebate payments from drugmakers based on the list price of drugs. The FTC estimates the agreement could save patients as much as $7 billion over a decade. https://www.reuters.com/world/cigna-settles-ftc-insulin-case-commits-overhauling-drug-pricing-2026-02-04/ XX Audio? Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law. Extends the SDP through December 31, 2026, and increases funding from $160 million to $200 million annually. Strengthens overall funding for the National Institutes of Health (NIH) by $415 million. Increases diabetes research funding at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) by $10 million. Created by Congress and administered by the NIH, the SDP has contributed nearly $3.6 billion to T1D research and has played a role in nearly every major breakthrough in the field. A recent study conducted by Avalere Health shows that of the nearly 3.6 billion invested into the SDP by Congress since the establishment of the program, the Federal Government has realized $50 billion in healthcare savings through improved health outcomes from the use of SDP driven therapies and devices https://www.breakthrought1d.org/news-and-updates/congress-passes-bipartisan-extension-of-the-special-diabetes-program-securing-critical-t1d-research-funding/ XX Dexcom is rolling out what they're calling AI-enabled enhancements to Stelo, further transforming how users track and understand their glucose health. Expanded Smart Food Logging including a comprehensive nutrition database of more than 1M meals that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more. More ways to meal track including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution. A redesigned Daily Insights feature which will introduce a new interface with more personalized recommendations. The newest features will launch nationwide in the coming weeks.  XX Beta Bionics has received a warning letter from the Food and Drug Administration following an inspection last year, the company disclosed on Friday. The diabetes technology company said in a securities filing that the warning letter concerns non-conformities with the company's quality management system, medical device reporting, and correction and removals. The warning letter has not yet been posted by the FDA.   The company said in the filing that it has already taken actions to improve the processes described in the warning letter, and it is working on a written response to the FDA.   The firm does not expect the warning letter to affect the planned launch of a new insulin patch pump by the end of 2027. Beta Bionics unveiled a prototype of the device, called Mint, last year at the American Diabetes Association's Scientific Sessions. The company also does not expect the warning letter to affect its financial results. https://www.medtechdive.com/news/beta-bionics-receives-fda-warning-letter/811140/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3A+2026-02-04+MedTech+Dive+%5Bissue%3A81423%5D&utm_term=MedTech+Dive&fbclid=IwY2xjawPwhDZleHRuA2FlbQIxMABicmlkETFaUUcyYmNQWldjZ2xudElic3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHouF8M3IstTyslPRgeHWUWVVdOAGOtzPWt_yNFcj9eYruqSPz3e86Iwcbpt8_aem_7q4D97vJVjHKfEwvoyUpgw XX Sequel Med Tech is reviewing co-founder Dean Kamen's ties to Jeffrey Epstein after recently released documents revealed new details about the longstanding relationship between the two men. The documents show that Kamen visited Epstein's island, and remained in contact with him for years after Epstein was convicted of sex crimes involving minors. Kamen has not been accused of any wrongdoing. In a statement, Sequel Med Tech said the Manchester-based company is aware of the documents pertaining to Kamen and – quote - "Sequel's Board of Directors has unanimously decided to engage an external law firm to review these disclosures and provide recommendations aligned with our mission to serve people living with diabetes," Kamen has not issued a statement regarding his reported connection to Epstein.   https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.nbcboston.com/news/local/nh-inventor-placed-on-leave-after-epstein-messages-surface-report-says/3888569/ XX Abbot reports 860 serious injuries linked to the recall of some of its glucose monitoring sensors. We told you about this recall late last year, these numbers are an FDA update.     Abbott said the sensors can provide incorrect glucose readings over extended periods, which could lead to users making dangerous treatment decisions, including eating excessive carbohydrates along with skipping or delaying insulin doses, potentially leading to serious health risks. The company said it has identified and resolved the cause of the issue, which relates to one production line among several that make Libre 3 and Libre 3 Plus sensors.   https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-recalls-glucose-sensors-after-seven-deaths-linked-faulty-readings-2026-02-04/ XX Updates from Medtronic & Senseonics – and a first from Nick Jonas.. right after this..   I'm excited to share that the FDA has cleared the MiniMed 780G system with the Instinct sensor, made by Abbott, for people with type 2 diabetes.  Medicare has also now approved coverage for the Instinct sensor for use with the MiniMed 780G system. This clearance and expanded coverage mean more people will have access to pairing our most advanced automated insulin delivery technology with the Instinct sensor, that offers a smaller, 15-day sensor experience.  They're also launching the MiniMed 780G system Pump Evaluation Program.  This program gives individuals living with diabetes the ability to try the full MiniMed 780G system at no cost for 30 days.† This includes the pump, the sensor of their choice, one month of infusion sets and reservoirs, everything but the insulin. They'll contact your doctor for you to get a prescription and get the process rolling. https://www.medtronicdiabetes.com/pump-evaluation-program XX Senseonics announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval – that's European clearance.  This comes on the heels of the launch of Eversense 365 with Sequel Med Tech's twiist pump, marking the first pump integration for the CGM. Senseonics plans to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months. Meanwhile, Senseonics continues to work toward an FDA investigational device exemption (IDE) submission for its next-generation Gemini transmitter-less CGM by the end of this year. https://www.drugdeliverybusiness.com/senseonics-ce-mark-eversense-365-cgm/ XX A huge shout out to Dr. Emily Blum, who just accomplished riding 100 miles in Antarctica for Breakthrough T1D! Despite having no direct connection to Type 1 Diabetes, Emily has been riding and fundraising for BreakthroughT1D for 10 years now. She is an integral part of the Georgia Ride team, training and riding many miles, and most importantly has raised tens of thousands of dollars to support the cause of ridding the world of T1D. She is surgeon and deeply involved with medical innovation, with an incredibly busy schedule, but jumped at the chance to take on the challenge of riding a century on every continent. Having already completed North America, Europe, Australia, Asia, and now Antarctica, only Africa and South America remain. Emily rides on and continues to be an inspiration to everyone who meets her. XX   https://diabetes-connections.com/t1d-connection-and-people-magazine-elise-zach-share-their-story/ XX Nick Jonas's becomes the first artist ever to wear a CGM on an album cover - new upcoming solo album Sunday Best, releasing Feb. 6.  The release says: This marks a powerful step forward in normalizing diabetes and raising awareness for the condition on a global scale. This moment adds to the growing visibility of diabetes in pop culture, alongside milestones like a Type 1 diabetes Barbie and Pixar characters wearing diabetes technology.